InvestorsHub Logo
Followers 166
Posts 36223
Boards Moderated 6
Alias Born 10/20/2019

Re: budfoxfun post# 2594

Wednesday, 11/30/2022 2:21:15 PM

Wednesday, November 30, 2022 2:21:15 PM

Post# of 2792
$NBIO - "This issuance strengthens our growing IP portfolio in our brain cancer treatment using Pritumumab, a unique natural antibody that crosses the blood brain barrier," said Sean Carrick, CEO of Nascent. "As we conclude our Phase I trial, this patent enhances our milestone achievements of moving the asset forward."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NBIO News